Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 280582-25-4 | MDL No. : | MFCD21648476 |
Formula : | C6H6Cl2N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LDWUISBWFCSUNG-UHFFFAOYSA-N |
M.W : | 193.03 | Pubchem ID : | 15565270 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 43.35 |
TPSA : | 35.01 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.73 cm/s |
Log Po/w (iLOGP) : | 2.28 |
Log Po/w (XLOGP3) : | 2.46 |
Log Po/w (WLOGP) : | 2.18 |
Log Po/w (MLOGP) : | 0.88 |
Log Po/w (SILICOS-IT) : | 2.47 |
Consensus Log Po/w : | 2.06 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.86 |
Solubility : | 0.268 mg/ml ; 0.00139 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.84 |
Solubility : | 0.28 mg/ml ; 0.00145 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.42 |
Solubility : | 0.0734 mg/ml ; 0.00038 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.15 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35.57% | Reflux | 2,4-Dichloro-5-ethoxy-pyrimidine[0095] In ice bath, dimethyl-phenyl-amine (5.21ml, 1.0 eq) was added dropwise to slurry of 5-ethoxy-pyrimidine-2,4-diol (6.45 g, 1.0 eq) in POCl3 (20 ml, 5.0 eq) and refluxed overnight. Excess POCl3 was evaporated in vacuo and the residue was poured into ice-water. After formation of precipitates, the mixture was filtered and dried solid in vacuo. A product was obtained as a white solid (2.84 g, 35.57percent)1H NMR (500 MHz, CDCl3-di): 51.47-1.50(m, 3H), 4.16-4.20(m, 2H), 8.13(s, 1H) |
[ 19646-07-2 ]
2,4-Dichloro-5-methoxypyrimidine
Similarity: 0.97
[ 60703-46-0 ]
2,4,6-Trichloro-5-methoxypyrimidine
Similarity: 0.85
[ 91183-17-4 ]
5-(Benzyloxy)-2,4-dichloropyrimidine
Similarity: 0.81
[ 19646-07-2 ]
2,4-Dichloro-5-methoxypyrimidine
Similarity: 0.97
[ 60703-46-0 ]
2,4,6-Trichloro-5-methoxypyrimidine
Similarity: 0.85
[ 91183-17-4 ]
5-(Benzyloxy)-2,4-dichloropyrimidine
Similarity: 0.81
[ 19646-07-2 ]
2,4-Dichloro-5-methoxypyrimidine
Similarity: 0.97
[ 60703-46-0 ]
2,4,6-Trichloro-5-methoxypyrimidine
Similarity: 0.85
[ 91183-17-4 ]
5-(Benzyloxy)-2,4-dichloropyrimidine
Similarity: 0.81